217 related articles for article (PubMed ID: 14471688)
1. [The consumption of antihemophilic globulin and the development of thromboplastin accelerator power in the adsorbed plasma-recalcified serum mixture. The problem of the responsible serum substrate].
MAYER G; MAYER S; WAITZ R
Rev Fr Etud Clin Biol; 1961 Nov; 6():924-8. PubMed ID: 14471688
[No Abstract] [Full Text] [Related]
2. [Effects of incubation on the anthemophilic globulin of adsorbed plasma and of adsorbed plasma-serum mixture. Absence of true consumption of the anthemophilic globulin and of development of a thromboplastin-accelerator power].
MAYER G; MAYER S
C R Seances Soc Biol Fil; 1961; 155():653-6. PubMed ID: 14471691
[No Abstract] [Full Text] [Related]
3. [Method of study of the thromboplastin-accelerator power and of the antithemophilic globulin consumption of the 1st intermediary products].
MAYER G; MAYER S; WAITZ R
Rev Fr Etud Clin Biol; 1961 Mar; 6():301-3. PubMed ID: 13768565
[No Abstract] [Full Text] [Related]
4. [Hemophilia A with presence in the serum of a specific inhibitor of antihemophilic B globulin].
STEFANOVIC S; ROLOVIC Z; BOZINOVIC L
Hemostase; 1961 Jun; 1():135-41. PubMed ID: 13916528
[No Abstract] [Full Text] [Related]
5. Serum accelerator factors and antihemophilic factor (AHF) in early phases of clotting.
GRAHAM JB; LANGDELL RD; MORRISON FC; BRINKHOUS KM
Proc Soc Exp Biol Med; 1954 Oct; 87(1):45-8. PubMed ID: 13224672
[No Abstract] [Full Text] [Related]
6. The antihaemophilic-globulin concentration in the plasma of female carriers of haemophilia.
GARDIKAS C; KATSIROUMBAS P; KOTTAS C
Br J Haematol; 1957 Oct; 3(4):377-8. PubMed ID: 13479686
[No Abstract] [Full Text] [Related]
7. The mode of action and aetiology of antihaemophilic globulin inhibitors.
BIGGS R; BIDWELL E; MACFARLANE RG
Sang; 1959; 30():340-51. PubMed ID: 13800639
[No Abstract] [Full Text] [Related]
8. [Comparative determination of the antihemophilic globulin in both sexes].
FISCHER J; LANDBECK G; LENZ W
Klin Wochenschr; 1958 Jan; 36(1):20-2. PubMed ID: 13540108
[No Abstract] [Full Text] [Related]
9. [Consumption of antihemophilic globulin and thromboplastin-accelerating activity of an initial intermediate product (I.I.P.). The Koller effect and consumption of the antihemophilic globulin (A.H.G.)].
MAYER G; MAYER S; WAITZ R
Rev Fr Etud Clin Biol; 1961 Feb; 6():168-72. PubMed ID: 13768564
[No Abstract] [Full Text] [Related]
10. A method for the study of antihaemophilic globulin inhibitors with reference to six cases.
BIGGS R; BIDWELL E
Br J Haematol; 1959 Oct; 5():379-95. PubMed ID: 13800640
[No Abstract] [Full Text] [Related]
11. In-vivo study on the relation between Bridge anticoagulant and antihaemophilic globulin.
NOUR-ELDIN F; WILKINSON JF
Br J Haematol; 1958 Jul; 4(3):292-301. PubMed ID: 13572740
[No Abstract] [Full Text] [Related]
12. [Prothrombin level in hemophilic blood after the addition in vitro of Cohn's fraction Ia (antihemophilic globulin)].
TROPEANO L
Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1892-4. PubMed ID: 13059109
[No Abstract] [Full Text] [Related]
13. [Consumption of antihemophilic globulin and development of thromboplastin-accelerating power in platelet-free plasma diluted 1:5, normal or pathological. Their relation to the conversion of prothrombin].
MAYER G; MAYER S
C R Seances Soc Biol Fil; 1961; 155():1687-90. PubMed ID: 14471689
[No Abstract] [Full Text] [Related]
14. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
[No Abstract] [Full Text] [Related]
15. [The fate of antihemophilic globulin in recalcified adsorbed plasma and effect of prothrombin on its consumption].
MAYER G; MAYER S
C R Seances Soc Biol Fil; 1961; 155():892-5. PubMed ID: 14471693
[No Abstract] [Full Text] [Related]
16. [Does lyophilization cause the appearance of a non-specific thromboplastic activity in the blood? Study of the antihemophilic factors A and B].
DUCOS J; BIERME R
C R Seances Soc Biol Fil; 1960; 154():808-12. PubMed ID: 13724735
[No Abstract] [Full Text] [Related]
17. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
Guimbretére J
Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
[No Abstract] [Full Text] [Related]
18. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
BRECKENRIDGE RT; RATNOFF CD
Blood; 1962 Aug; 20():137-49. PubMed ID: 13872719
[No Abstract] [Full Text] [Related]
19. Plasma antihemophilic factor biological and clinical aspects.
BRINKHOUS KM
Sang; 1954; 25(7):738-41. PubMed ID: 13225559
[No Abstract] [Full Text] [Related]
20. [Hemophilic syndromes; Aggeler's method of preparing plasma and serum fractions containing antihemophilic globulin and the plasma thromboplastin component].
MARCACCI M
Riv Ist Sieroter Ital; 1954; 29(1):104-14. PubMed ID: 13168124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
